RP
Raptor Pharmaceuticals Corp. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by SAGER ERICH, was filed 09 Nov 2006.
Raptor Pharmaceuticals Corp.: what insiders have been doing
We have very little insider data for Raptor Pharmaceuticals Corp. so far: the most recent filing dates from 21 October 2008. With so few records, no pattern can be drawn yet. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
5
Thresholds
n/a
Buy Volume
€4,695
1 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 21 October 2008
Declarations5 total
- 100,000 shares0Common StockSEC:0001203944-08-000031:0
- 100,000 shares0Common StockSEC:0001203944-08-000008:0
- 200,000 shares0Common StockSEC:0001203944-07-000051:0
- 2,500 shares@ US$0.60Common StockSEC:0001203944-07-000020:0
- 10,000 shares@ US$0.60Common StockSEC:0001203944-06-000018:0Canonical exit: 5 Feb 2007 (T+90)
5 of 5 declarations
About Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. is a biopharmaceutical company focused on developing treatments for rare diseases. It is listed on NASDAQ under the ticker RPTP.
